**Key characteristics:**
* The protein is a transmembrane protein with a molecular weight of approximately 150 kDa.
* It is a pseudogene, meaning that it is not expressed in the mature genome but is transcribed and translated during development.
* The protein is a key regulator of the farnesyl diphosphate pathway, which is a signaling pathway that is involved in a variety of cellular processes, including cell growth, differentiation, and apoptosis.
* It is a negative regulator of the pathway, meaning that it inhibits the activity of the pathway.
* The protein is also involved in the regulation of cell migration and adhesion.
**Pathways and functions:**
* The farnesyl diphosphate pathway is a signaling pathway that is involved in a variety of cellular processes, including cell growth, differentiation, and apoptosis.
* The protein encoded by the FDPSP3 gene is a key regulator of the farnesyl diphosphate pathway.
* It inhibits the activity of the pathway by binding to the FGF receptor and preventing it from binding to its ligand, FGF.
* This leads to a decrease in the activity of the pathway and inhibits cell growth, differentiation, and apoptosis.
**Clinical significance:**
* Mutations in the FDPSP3 gene have been linked to a number of human diseases, including cancer and developmental disorders.
* The protein encoded by the FDPSP3 gene is a potential target for cancer therapy.
* Inhibition of the farnesyl diphosphate pathway has been shown to be effective in inhibiting cancer growth and metastasis.
Disclaimer: This summary is generated by an AI language model and may contain inaccuracies or hallucinations. However, it is cross-referenced with curated gene expression data from major biological sources. Please verify the information before use.
